Huilong Chen
Impact in
- Infectious Diseases top 0.2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 0.5%
- Long-Term Effects of COVID-19
Papers in
- Immunology 13
- IL-33, ST2, and ILC Pathways 6
- Co-authors
- Qin NingMeifang HanHaijing YuDi WuJianping ZhaoWei GuoXiaoping LuoHongwu Wang
- Journals
- Gene (3 papers)Biomedicine & Pharmacotherapy (2 papers)Biochemical and Biophysical Research Communications (2 papers)Chemical and Biological Technologies in Agriculture (2 papers)Frontiers in Genetics (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Huilong Chen
78 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Infectious Diseases 2.9k
- Neurology 1.6k
- Applied Microbiology and Biotechnology 74
- Critical Care and Intensive Care Medicine 133
- Obstetrics and Gynecology 191
Countries citing papers authored by Huilong Chen
This map shows the geographic impact of Huilong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huilong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huilong Chen more than expected).
Fields of papers citing papers by Huilong Chen
This network shows the impact of papers produced by Huilong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huilong Chen. The network helps show where Huilong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Huilong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | Low‐Volatility Fused‐Ring Solid Additive Engineering for Synergistically Elongating Exciton Lifetime and Mitigating Trap Density Toward Organic Solar Cells of 20.5% Efficiency Hit paper breakdown → | 2025 | 25 |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 21 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 33 | |
| 14 | 2022 | 20 | |
| 15 | 2020 | 8 | |
| 16 | 2018 | 16 | |
| 17 | 2017 | 64 | |
| 18 | 2015 | 8 | |
| 19 | IL-21 does not involve in OVA-induced airway remodeling and chronic airway inflammation. | 2015 | 7 |
| 20 | 2013 | 12 |
About Huilong Chen
Huilong Chen is a scholar working on Immunology, Cancer Research, Applied Microbiology and Biotechnology, Polymers and Plastics and Infectious Diseases, having authored 82 papers that have together received 4.6k indexed citations. Recurring topics across this work include Hydraulic and Pneumatic Systems (9 papers), Cavitation Phenomena in Pumps (7 papers), Asthma and respiratory diseases (7 papers), IL-33, ST2, and ILC Pathways (6 papers), COVID-19 Clinical Research Studies (6 papers), Organic Electronics and Photovoltaics (5 papers), Perovskite Materials and Applications (5 papers) and Conducting polymers and applications (5 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Neurology (1.6k citations), Applied Microbiology and Biotechnology (74 citations), Critical Care and Intensive Care Medicine (133 citations) and Obstetrics and Gynecology (191 citations). Huilong Chen has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Qin Ning, Meifang Han, Haijing Yu, Di Wu, Jianping Zhao, Wei Guo, Xiaoping Luo, Hongwu Wang, Yong Cao and Xiaoyun Zhang. Their work appears in journals such as Gene, Biomedicine & Pharmacotherapy, Biochemical and Biophysical Research Communications, Chemical and Biological Technologies in Agriculture and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.